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The axial structure of the bacterial flagellum consists of three parts: the filament as a helical propeller; the hook as a universal joint; and the rod a drive shaft connecting the hook and the MS ring. The construction of the axial structure, which occurs at its distal end, requires cap complexes attached to the growing end. FlgD and FliD are cap proteins necessary for hook and filament growth, respectively. Because the rod penetrates the peptidoglycan (PG) layer, the rod cap is thought to have a PG-hydrolyzing activity. FlgJ is a putative rod cap protein. The N-terminal region of FlgJ interacts with the rod proteins and the C-terminal region shows a sequence similarity to muramidase, such as autolysin, muramidase2 and AcmA. To understand the mechanisms of rod formation, we solved the crystal structure of a C-terminal fragment of FlgJ at 1.7 Å; resolution using diffraction data collected at SPring-8 beamline BL41XU. The putative active site structure is similar to that of lysozyme, although no significant sequence similarity is found between FlgJ and lysozyme. Based on the structure, we identified residues essential for the PG-hydrolyzing activity and confirmed them by mutational analyses. The three dimensional structure of a complete Hypocrea jecorina glucoamylase has been determined at 1.8 Å resolution. Previous structures of other fungal and yeast glucoamylase catalytic and starch binding domains have been determined separately, this is the first intact structure that allows visualization of the juxtaposition of the starch binding domain relative to the catalytic domain, including the 37 residue linker segment. The detailed interactions we see between the catalytic and the starch binding domains are confirmed in a second independent structure determination of the enzyme in a second crystal form. This second structure model exhibits an identical conformation compared to the first structure model. The proposed starch binding regions for the starch binding domain are aligned with the catalytic domain in the three-dimensional structure in a manner that supports the hypothesis that the starch binding domain serves to target the glucoamylase at sites where the starch granular matrix is disrupted and where the enzyme might most effectively function. In most organisms, citrate synthase (CS) is a dimer of identical subunits (approx. 400 amino acids). This enzyme catalyzes the entry point of carbon (in the form of acetyl-CoA) into the tricarboxylic acid cycle, a critical energy-producing metabolic process. This form of CS is designated Type I and is not regulated. In contrast, Gram-negative bacteria have a different kind of CS, designated Type II, which form hexamers that are allosterically inhibited by NADH. Our structural studies of the Gram-negative E. coli Type II CS (426 amino acids) identifies a reversible folding element (residues 262-298) adjacent to the active site that controls functionality, and which is unfolded C257 in the T-state (inactive; NADH bound). Notably, in the unregulated Type I CS these same residues form a stable folded region composed of two large helices that are a key part of the binding site for acetylCoA. Kinetic analyses of both types of CS indicate a similar catalytic mechanism, suggesting that in the active R-state of E. coli Type II CS, the conformation of residues 262-298 will be similar to that seen in the unregulated Type I enzymes. This uniquely evolved functionality switch in the Type II CS provides the opportunity to study a novel aspect of the protein folding problem, namely how to engineer the property of reversible instability into a formerly stably folded region. We have specifically designed and determined the structures of variant enzymes to gain a better understanding of the mechanistic features of this allosterically controlled regulatory folding/unfolding system. This has resulted in a series of stepwise structural snap shots of the refolding process in going from the T to R-states in Type II CS. Supported by the Natural Sciences and Engineering Research Council of Canada. Human membrane integrated protein is one of the most exciting target for protein crystallographers, due to the difficulties in protein preparation as well as crystallographic work. In the year 2007, the structures of three human membrane proteins were determined crystallographically first. Leukotriene C4 synthase (LTC4S) is one of the three human membrane integrated proteins. LTC4S, which is a membrane integrated protein existing in nuclear membrane, catalyzes the conjugation between leukotriene (LT) A4 and glutathione (GSH) to form LTC4. LTC4 and its metabolites LTD4 and LTE4 are components of slow reacting substance of anaphylaxis, and they are called cysteinyl leukotrienes (Cys-LTs) because they have a cysteine moiety commonly. Cys-LTs are lipid mediators involved in smooth muscle constriction and inflammation, particularly in asthma. LTC4S is the membrane protein responsible for the biosynthesis of Cys-LTs and a potential target for drug discovery. The crystal structure of human LTC4S was determined at 3.3Å resolution using the recombinant LTC4S. We established the over-expression system using Schizosaccharomyces pombe, and we also used the expression system for the preparation of the selenomethionine derivative of LTC4S with a Leu121Met mutation for the MAD phase calculation as well as the native LTC4S with a histidine tag. In the crystal structure LTC4S forms trimer structure, and there is a V-shape substrate binding cleft between two adjacent monomers. GSH, which is one of the substrates, was co-crystallized with LTC4S, bound at the upper space of the V-shape cleft. Based on the crystal structure, we proposed the acid-base catalytic mechanism, and Arg31 from a monomer and Arg104 from the other monomer exert the acid and base, respectively.
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